ABSTRACT Objective: To describe the clinical characteristics, management, and fetal outcomes of patients diagnosed with gestational diabetes mellitus (GDM) or overt diabetes (OD) during pregnancy who followed up at a public healthcare referral center in Brazil. Materials and methods: A retrospective cohort study based on the medical records of women diagnosed with dysglycemia during pregnancy between January 2015 and July 2017 was conducted. Results: Out of 224 pregnant women evaluated, 70% were overweight/obese. GDM was observed in 78.6% of pregnant women, while 21.4% presented with OD. Approximately 59% of patients could be diagnosed with GDM or OD by fasting plasma glucose (FPG) alterations alone. Exclusive diet therapy was used in 50.9% of patients. The need for insulin therapy was higher in OD patients (60.4%) than in GDM patients (38.1%) (p = 0.006). Women who needed insulin (n = 96) had a mean initial dose of 0.33 IU/kg (±0.27) and a final value of 0.39 IU/kg (±0.34). The cesarean rate was 74.3%. The fetal outcomes evaluated were macrosomia (2.15%), large for gestational age (LGA) fetus (15.83%), intensive care unit (ICU) need (4.32%), Apgar score ≤7 (6.47%), hypoglycemia (14.39%) and jaundice (16.55%). Conclusions: Patients with GDM and OD presented with several similar clinical features. Approximately half of the patients presented with adequate glycemic control only with diet management. Patients with OD presented a higher need for insulin therapy. Although overweight and obesity were frequent within both groups, they could possibly explain many of our findings.

Resumo Dados comparando medidas antropométricas, análise de impedância bioelétrica (BIA) e parâmetros de absorciometria de raios-X de dupla energia (DXA) são de alguma forma limitados e conflitantes. O objetivo deste estudo foi correlacionar parâmetros antropométricos de BIA e de DXA entre adultos obesos brasileiros, com foco na comparação com tecido adiposo visceral (TAV) obtido na DXA e no valor das medidas antropométricas. Cinquenta participantes voluntários foram inscritos. O teste de correlação de Spearman foi utilizado para avaliar a correlação do TAV com medidas antropométricas, da BIA e de outros parâmetros da DXA. O coeficiente de correlação intra-classe (ICC) foi usado para avaliar a concordância entre massa magra (MM), massa gorda (MG), % de gordura corporal (%GC) e % de gordura corporal na parte superior do corpo (%GSC) obtidos por BIA e DXA. A maioria era do sexo feminino (80%) e apresentava índice de massa corporal médio (IMC) de 39,0 (± 6,4) kg / m2. As únicas medidas antropométricas que mostraram uma forte correlação com o TAV foram a circunferência abdominal (CA) e a relação cintura / estatura (RCE), mas apenas no sexo feminino. Houve uma correlação muito boa para MM [ICC = 0,951 (IC = 0,913 - 0,972)], MG [ICC = 0,987 (IC = 0,977 - 0,993)], % GC [ICC = 0,961 (IC = 0,931-0,978)], e % GSC [ICC = 0,873 (IC = 0,776 - 0,928)], entre os dados coletados através de BIA e DXA. Dentre as medidas antropométricas avaliadas, apenas a CA e a RCE parecem estimar pacientes com distribuição de gordura abdominal e maior TAV no sexo feminino. A DXA e a BIA mostraram-se semelhantes para a avaliação de MM, MG,% GC e % GSC, embora a DXA tenha a vantagem de estimar o VAT.

Abstract Data comparing anthropometric measurements, bioelectrical impedance analysis (BIA) and dual-energy X-ray absortiometry (DXA) parameters are somehow limited and conflicting. The objective of this study was to correlate anthropometric, BIA and DXA parameters among obese Brazilian adults with focus on the comparison with visceral adipose tissue (VAT) obtained from DXA and in the value of antropometric measurements. Fifty voluntary participants were enrolled. The Spearman correlation test was used to assess the correlation of VAT with anthropometric measurements, BIA and other DXA parameters. The intra-class correlation coefficient (ICC) was used to evaluate concordance between lean mass (LM), fat mass (FM), %body fat (%BF) and %upper body fat (%UBF) obtained from BIA and DXA. Most were female (80%) and had an average body index mass (BMI) of 39.0 (± 6.4) kg/m2. The only anthropometric measurements showing a strong correlation with VAT were abdominal circumference (AC) and waist-to-height ratio (WHtR), but just in females. There was a very good correlation for LM [ICC = 0.951 (CI = 0.913 - 0.972)], FM [ICC = 0.987 (CI = 0.977 – 0.993)], %BF [ICC = 0.961 (CI = 0.931-0.978)], and %UBF [ICC = 0.873 (CI = 0.776 – 0.928)], between data collected through BIA and DXA. Among the anthropometric measurements assessed, only AC and WHtR seems to estimate patients with abdominal fat distribution and higher VAT in females. DXA and BIA proved similar for the evaluation of LM, FM, %BF and %UBF, although DXA has the advantage of estimating VAT.

Objective To evaluate the data of continuous subcutaneous insulin infusion protocol (CSII) for diabetics waived by the Health State Secretariat of Distrito Federal (HSSDF) and therapeutic responses three months after the transfer of multiple daily injections regimen for CSII. Subjects and methods Eighty patients (49 female) took part in this experimental study, mean age and disease duration were 27.9 years and 13 years, respectively; 96% patients had type 1 diabetes mellitus. Results The entire sample (ECO) and 3 subgroups (group 1 – A1c decrease, group 2 – A1c stable, and group 3 – A1c increase), stratified according to a ≥ 0.5% change in A1c, were analyzed. Group 1 involved 64% of the patients. The ECO showed a significant A1c decrease: MDI 8.1 ± 1.4% vs. CSII 7.3 ± 0.9%, p < 0.0001 (0.8% difference pro CSII therapy). Group 1 demonstrated an A1c decrease from 8.7% to 7.3% (1.4% difference). Group 2 mean A1c was 7.1%. Rate of hypoglycemia (< 50 mg/dL) decreased 61% in the ECO and 79% in Group 2. Conclusion This study reinforces the safety and efficacy of CSII with a robust A1c reduction and hypoglycemia. The pioneer care HSSDF ambulatory attests to be achievable the free dispensing by Unified Health System (UHS) following a protocol, and this approach results in less wastage to the patient and represents a rational policy of therapy with CSII for UHS. Arch Endocrinol Metab. 2015;59(1):23-8

INTRODUÇÃO: O diabetes tipo 2 (DM) é uma doença crônica que tem impacto socioeconômico importante nos dias atuais. Medidas de prevenção, detecção precoce e tratamento se mostram importantes para a diminuição da taxa de morbimortalidade dessa síndrome. OBJETIVOS: Verificar e comparar entre idosos, portadores ou não de diabetes mellitus, os que possuem maior limitação de mobilidade articular (LMA); analisar a relação da LMA com a idade, o tempo de DM, a presença de sinal da prece (SP), o risco neuropático (RN) e a influência dos exercícios utilizados na fisioterapia. MATERIAIS E MÉTODOS: Os indivíduos foram divididos em três grupos com n = 15 cada, sendo grupo C (controle), grupo DM, grupo DMF (DM em tratamento fisioterapêutico, por meio de alongamentos e exercícios leves). Foram avaliadas as goniometrias de tornozelos e punhos, SP e RN, bem como relacionou-se a média das amplitudes de movimento (ADMs) entre os grupos com a idade, o tempo de DM, o SP e o RN. RESULTADOS E CONCLUSÕES: A média das ADMs nos grupos foram C > DMF > DM, de forma significativa (p < 0,05), exceto flexão de punho direito. Observa-se a influência da fisioterapia (DMF > DM), significante no movimento de extensão de punho. Quanto maior a idade e o tempo de DM maior a tendência de LMA, porém, essas diferenças não foram significativas. No presente estudo, o RN e o SP não são os únicos determinantes da LMA. Conclui-se que o diabetes interfere significativamente na ADM e que houve influência benéfica da fisioterapia, por meio de alongamentos e exercícios leves.

INTRODUCTION: Type 2 diabetes (T2D) is a chronical disease with an important socioeconomic impact nowadays. Prevention, early detection and treatment are important to morbidity and mortality reduction. OBJECTIVES: To verify and compare the which have the greatest limitation of joint mobility (LJM), the LJM relation to age, the time of diagnosis of T2D, the presence of a prayer signal (PS), the risk neuropathic (RN) and the influence of exercises used in physiotherapy in elderly T2D and non T2D individuals. MATERIALS AND METHODS: The subjects were accomplished in three groups being control group (C; n = 15); T2D group (T2D; n=15) and T2D in physiotherapeutic treatment - stretching and light resistance exercises (T2DPhys; n = 15). Goniometry of the ankles and wrists, PS and RN were evaluated and the average of range of motion (ROM) was associated between groups accordingly to the age, time of diagnosis of T2D, PS and RN. RESULTS AND CONCLUSIONS: The average ROM in groups were C > T2DPhys > T2D, significantly (p < 0.05), except for right wrist flexion. There was a significant (p < 0.05) influence of physiotherapy (T2DPhys > T2D)in the wrist extension movement. The LJM were higher in older individual and in T2S with more time with disease but these relations were not significant. In this study, the RN and PS were not the only determinants of LJM. It was concluded that T2D interferes negatively and significantly in ROM and the physiotherapy treatment through stretching and resistance light exercises exerted beneficial influences on these parameters in the T2D.

OBJETIVO: Avaliar a prevalência de sobrepeso e obesidade em pacientes ambulatoriais com diabetes mellitus tipo 2 (DM2) em diferentes regiões do Brasil. PACIENTES E MÉTODOS: Avaliamos aleatoriamente 2.519 pacientes em 11 hospitais, 2 ambulatórios especializados e um posto de saúde em 10 cidades brasileiras. Consideramos sobrepeso um índice de massa corporal (IMC) > 25 e obesidade um IMC > 30 kg/m². O controle glicêmico (CG) foi avaliado pelo índice de CG [ICG= HbA1 e ou HbA1c do paciente/limite superior de normalidade do método x 100]. RESULTADOS: Os pacientes tinham idade de 58,8 ± 11,6 anos, tempo de diagnóstico clínico de DM de 9,0 ± 7,3 anos, IMC de 28,3 ± 5,2 kg/m², e 39% eram do sexo masculino. Do total da amostra, 265 pacientes (10,5%) não apresentavam avaliação do IMC. Os pacientes da região Nordeste apresentaram menor IMC em comparação com os das regiões Centro-Oeste, Sudeste e Sul, respectivamente (26,4 ± 4,7 vs. 27,9 ± 4,8 vs. 29,2 ± 5,1 vs. 29,4 ± 5,4 kg/m²; p< 0,001). Houve maior prevalência de obesidade na região Sudeste e Sul em comparação à região Nordeste (p< 0,001) e nos pacientes do sexo feminino, respectivamente (69 vs. 31%; p< 0,001). Os pacientes com peso normal apresentaram menor ICG. Aqueles em tratamento com associação de duas ou mais drogas orais e associação de insulina + droga oral apresentaram maior IMC do que aqueles em tratamento com dieta, hipoglicemiante oral e insulina; p< 0,001. O IMC não diferiu entre os pacientes assistidos ou não por especialistas. CONCLUSÕES: Da população estudada, 75% não estava na faixa de peso ideal, sendo que um terço tinha obesidade. Nossos dados indicam que o sobrepeso e a obesidade já atingem um percentual de pacientes com DM2 no Brasil semelhante ao relatado em estudos europeus, mas ainda menor do que o observado nos EUA. A prevalência de obesidade nos pacientes diabéticos foi três vezes maior do que a observada na população brasileira em geral de acordo com os dados do IBGE.

AIM: To evaluate the prevalence of overweight and obesity in type 2 diabetic (DM2) outpatients from different regions of Brazil. PATIENTS AND METHODS: We studied 2,519 randomly selected patients, from 11 hospitals, 2 endocrine and one general public care clinics from 10 cities. Overweight was defined as body-mass index (BMI) > 25 and obesity as BMI > 30 kg/m². Glycemic control (GC) was evaluated by GC index (GCI= patient's HbA1 or HbA1c/upper limit of normal for the method x 100). RESULTS: 39% of the population studied was male, the mean age was 58.8 ± 11.6 y, the duration from clinical diagnosis of DM2 was 9.0 ± 7.3y, and BMI was 28.3 ± 5.2 kg/m². No measurements of BMI were recorded from 265 patients (10.5%). Patients from the Northeast presented lower BMI as compared with those from the Midwest, Southeast and South areas, respectively (26.4 ± 4.7 vs. 27.9 ± 4.8 vs. 29.2 ± 5.1 vs. 29.4 ± 5.4 kg/m²; p< 0.001). A greater prevalence of obesity was observed in the Southeast and South areas as compared to the Northeast (p< 0.001), as well as in the female group, respectively (69% vs. 31%; p< 0.001). Normal weight patients presented lower GCI. Patients being treated with two or more oral drugs and an association of insulin plus oral drug presented greater BMI values than those being treated with diet, oral hypoglycemic agents and insulin p< 0.001. The BMI of patients treated by a specialist did not differ from those treated by a generalist. CONCLUSIONS: 75% of our sample was out of adequate BMI and 30% was obese. The percentage of patients with overweight and obesity was comparable to those found in similar European studies but still lower than those found in the USA. The prevalence of obesity in diabetic patients was three times higher than in the overall Brazilian population according to data from the Brazilian Institute of Geography and Statistics (IBGE).